-
<![CDATA[Phase 3 Topline Results Show Rituximab Noninferior to Cladribine in Reducing New or Enlarging Brain Lesions in Relapsing-Remitting MS]]>
26 Sep 2025 02:44 GMT
… positive B cells whereas cladribine induces selective lymphocyte … more frequently in the cladribine group, affecting 89% … safety of rituximab versus cladribine in relapsing-remitting … effectiveness of rituximab and cladribine in relapsing-remitting multiple …
-
Reviewing the Power of Health and Wellness Coaching in Multiple Sclerosis Care
06 Aug 2025 06:46 GMT
… of chronic diseases such as multiple sclerosis (MS). According to a recently … at the 2025 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, held … it more.
Transcript edited for clarity. Click here for more coverage …
-
Not Getting the MS Drugs You Need? Maybe It’s Because You’re Female
05 Aug 2025 02:42 GMT
… highly effective at reducing multiple sclerosis relapses, according to … .”
Pregnancy Can Complicate Multiple Sclerosis Treatment
One big factor … safety and effectiveness of MS drugs during pregnancy, women … about the lack of clarity around the potential risks …
-
Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025
24 Sep 2025 12:30 GMT
… metabolism, restores mental clarity and reduces hangover symptoms … metabolism, restores mental clarity and reduces hangover symptoms … "), restores mental clarity, and reduces the … the underlying mechanism of multiple sclerosis, in preclinical models. …
-
Comparative Real-World Effectiveness of Rituximab vs Cladribine in Relapsing-Remitting Multiple Sclerosis
20 Aug 2025 15:29 GMT
… (Rituxan; Genentech) and cladribine (Mavenclad; Merck KGaA), … and Oslo University Hospital (cladribine). The treatment assignment was … option compared with cladribine for reducing radiologic … of rituximab and cladribine in relapsing-remitting multiple …
-
'Major leap forward': Mātai says new MRI method improves multiple sclerosis detection
10 Jul 2025 04:24 GMT
… both lesion detection and structural clarity,” Bydder said.
“This technology opens … supported by the New Zealand Multiple Sclerosis Research Trust (NZMRST) and the …
-
Target Trial Emulation Favors Rituximab’s Effectiveness Over Cladribine in Treating Multiple Sclerosis
15 Aug 2025 12:24 GMT
… had superior effectiveness over cladribine (Mavenclad; EMD Serono) … (n = 159) or cladribine (n = 126). Investigators … treated with rituximab vs cladribine had risk differences (RDs … effectiveness of rituximab and cladribine in relapsing–remitting multiple …
-
Immunic CEO discusses Phase 2 multiple sclerosis study success - ICYMI
28 Jun 2025 13:33 GMT
… vidofludimus calcium in relapsing-remitting multiple sclerosis (RRMS).
Proactive: Hello … calcium in relapsing remitting multiple sclerosis. The data shows a … you get diagnosed with multiple sclerosis, regardless if it… lightly edited for clarity and style
-
Immunic showcases MS drug data at BIO International Convention in...
21 Jun 2025 19:22 GMT
… , vidofludimus calcium, aimed at treating multiple sclerosis (MS).
Proactive: Hello you’re … asset with positive results in multiple sclerosis, and we’re also talking … have been lightly edited for clarity and style
-
Episode 6: How Can Ob/Gyn and Derm Partner on HS Care?
23 Sep 2025 14:44 GMT
… transcript has been edited for clarity. For more episodes, download the … pregnancy. A common one is multiple sclerosis. Again, these medications can oftentimes … of Biologic Therapies
Pregnancy and Multiple Sclerosis: An Update
Outcomes of Pregnancy …